Pharmaceutical composition, pharmaceutical preparation and method for preventing and controlling phyllotreta striolata
A technology for flea beetles and medicinal preparations, applied in the fields of botanical equipment and methods, animal repellents, plant growth regulators, etc. Reduced risk of spreading pathogenic bacteria, improved control effect, reduced root wound effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0084] A pharmaceutical composition for preventing and treating flea beetle, which is composed of active ingredient A and active ingredient B in a mass ratio of 3:7; wherein, the active ingredient A is compound 4, and the active ingredient B is thiamethoxam.
[0085] The pharmaceutical composition is used to prepare pharmaceutical preparations, the dosage form is seed treatment dispersible granules, and the formula is as follows:
[0086] 15 parts of compound 4, 35 parts of thiamethoxam, 2 parts of sodium lauryl sulfate, 3 parts of phenol sulfonate, 3 parts of starch, 4 parts of desmectite, 2 parts of polyethylene glycol, 2 parts of permanent Red and white carbon black are supplemented to 100 parts; the above components are mixed uniformly to prepare seed treatment dispersible granules with a mass percentage of the pharmaceutical composition of 50%.
Embodiment 2
[0088] A pharmaceutical composition for preventing and treating flea beetle, which is composed of active ingredient A and active ingredient B in a mass ratio of 1:1; wherein, the active ingredient A is compound 8, and the active ingredient B is clothianidin.
[0089] The pharmaceutical composition is used to prepare pharmaceutical preparations, the dosage form is a seed treatment suspension, and the formula is as follows:
[0090] 10 parts of compound 8, 10 parts of clothianidin, 3 parts of polycarboxylate, 2 parts of polyoxyethylene polyoxypropylene block copolymer, 3 parts of cellulose derivatives, 0.28 parts of xanthan gum, 2 parts of white carbon black, 0.2 parts of Cathone, 5 parts of ethylene glycol, 2 parts of permanent red, and water make up to 100 parts; the above-mentioned components are mixed uniformly, and the seed treatment suspension concentrate with a mass percentage of 20% of the pharmaceutical composition is prepared .
Embodiment 3
[0092] A pharmaceutical composition for preventing and treating flea beetle, which is composed of active ingredient A and active ingredient B at a mass ratio of 1:3; wherein, the active ingredient A is compound 1, and the active ingredient B is dinotefuran.
[0093] The pharmaceutical composition is used to prepare pharmaceutical preparations, and the dosage form is a soluble agent, and the formula is as follows:
[0094] 3 parts of compound 1, 9 parts of dinotefuran, 5 parts of fatty alcohol polyoxyethylene ether, 5 parts of polyaryl phenyl polyoxyethylene ether, 5 parts of castor oil polyoxyethylene ether, 8 parts of N,N-dimethyl ethyl ether Amidoamine, 15 parts of n-butanol, 5 parts of methanol, and water make up to 100 parts; the above components are mixed uniformly to prepare a soluble agent with a mass percentage of the pharmaceutical composition of 12%.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com